Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Elucidation of the Contribution of Active Site and Exosite Interactions to Affinity and Specificity of Peptidylic Serine Protease Inhibitors Using Non-Natural Arginine Analogs

Masood Hosseini, Longguang Jiang, Hans Peter Sørensen, Jan K. Jensen, Anni Christensen, Sarah Fogh, Cai Yuan, Lisbeth M. Andersen, Mingdong Huang, Peter A. Andreasen and Knud J. Jensen
Molecular Pharmacology October 2011, 80 (4) 585-597; DOI: https://doi.org/10.1124/mol.111.072280
Masood Hosseini
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Longguang Jiang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Peter Sørensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan K. Jensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anni Christensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Fogh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cai Yuan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisbeth M. Andersen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mingdong Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter A. Andreasen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Knud J. Jensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Abstract

There is increasing interest in developing peptides for pharmacological intervention with pathophysiological functions of serine proteases. From phage-displayed peptide libraries, we previously isolated peptidylic inhibitors of urokinase-type plasminogen activator, a potential target for intervention with cancer invasion. The two peptides, upain-1 (CSWRGLENHRMC) and mupain-1 (CPAYSRYLDC), are competitive inhibitors of human and murine urokinase-type plasminogen activator, respectively. Both have an Arg as the P1 residue, inserting into the S1 pocket in the active site of the enzymes, but their specificity depends to a large extent on interactions outside the enzymes' active sites, so-called exosite interactions. Here we describe upain-2 (CSWRGLENHAAC) and the synthesis of a number of upain-2 and mupain-1 variants in which the P1 Arg was substituted with novel non-natural Arg analogs and achieved considerable improvement in the affinity of the peptides to their targets. Using chimeras of human and murine urokinase-type plasminogen activator as well as X-ray crystallography, we delineated the relative contribution of the P1 residue and exosite interactions to the affinity and specificity of the inhibitors for their target enzyme. The effect of inserting a particular non-natural amino acid into the P1 position is determined by the fact that changes in interactions of the P1 residue in the S1 pocket lead to changed exosite interactions and vice versa. These findings are of general interest when the affinities and specificities of serine protease inhibitors to be used for pharmacological intervention are considered and could pave the way for potential drug candidates for the treatment of cancer.

Footnotes

  • ↵Embedded Image The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.

  • This work was supported by the National Natural Science Foundation of China [Grants 30811130467, 30973567, 30770429]; the Danish National Research Foundation [Grant 26-331-6]; the Lundbeck Foundation [Grant R19-A2173]; the Danish Cancer Society [Grant DP 07043, DP 08001]; the Danish Research Agency [Grant 272-06-0518]; and the Novo Nordisk Foundation [Grant R114-A11382].

  • All authors are affiliated with the Danish-Chinese Centre for Proteases and Cancer (http://www.proteasesandcancer.org).

  • Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.

    doi:10.1124/mol.111.072280.

  • ABBREVIATIONS:

    uPA
    urokinase-type plasminogen activator
    Fmoc
    9H-fluoren-9-ylmethoxycarbonyl
    Dap
    l-2,3-diaminopropionic acid
    Boc
    di-tert-butyl dicarbonate
    HPLC
    high-performance liquid chromatography
    HBTU
    N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide
    TFA
    trifluoroacetic acid
    HOBt
    N-hydroxybenzotriazole
    HOAt
    1-hydroxy-7-azabenzotriazole
    DIPEA
    N,N-diisopropylethylamine
    NMP
    N-methyl-2-pyrrolidone
    Alloc
    allyloxycarbonyl
    HRMS
    high-resolution mass spectrometry
    ES
    electrospray
    Cbz
    carboxybenzyl
    Fmoc-OSu
    9-fluorenylmethoxycarbonyl-N-hydroxysuccinimide
    MS
    mass spectrometry
    wt
    wild-type
    S-2444
    pyro-Glu-Gly-Arg-p-nitroanilide
    PDB
    Protein Data Bank.

  • Received March 19, 2011.
  • Accepted June 30, 2011.
  • Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 80 (4)
Molecular Pharmacology
Vol. 80, Issue 4
1 Oct 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Elucidation of the Contribution of Active Site and Exosite Interactions to Affinity and Specificity of Peptidylic Serine Protease Inhibitors Using Non-Natural Arginine Analogs
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Exosite Interactions of Peptidylic Serine Protease Inhibitors

Masood Hosseini, Longguang Jiang, Hans Peter Sørensen, Jan K. Jensen, Anni Christensen, Sarah Fogh, Cai Yuan, Lisbeth M. Andersen, Mingdong Huang, Peter A. Andreasen and Knud J. Jensen
Molecular Pharmacology October 1, 2011, 80 (4) 585-597; DOI: https://doi.org/10.1124/mol.111.072280

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Exosite Interactions of Peptidylic Serine Protease Inhibitors

Masood Hosseini, Longguang Jiang, Hans Peter Sørensen, Jan K. Jensen, Anni Christensen, Sarah Fogh, Cai Yuan, Lisbeth M. Andersen, Mingdong Huang, Peter A. Andreasen and Knud J. Jensen
Molecular Pharmacology October 1, 2011, 80 (4) 585-597; DOI: https://doi.org/10.1124/mol.111.072280
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics